John Choi

The University of Alabama

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Kikkeri N Naresh

Professor

University of Washington

UNITED STATES

View details

Javeed Iqbal

Professor,

University of Nebraska Medical Center

UNITED STATES

View details

Pankit Vachhani

The University of Alabama

UNITED STATES

View details

Brian Walker

Indiana State University

UNITED STATES

View details

Nicholas Cross

Professor of Human Genetics

University of Southampton

UNITED KINGDOM

View details

Karen M. Chisholm

University of Washington Medical Center

UNITED STATES

View details

Pedro Farinha

Clinical Professor

The University of British Columbia

CANADA

View details

Catalina Amador

Associate Professor

University of Miami Health System

UNITED STATES

View details

Shimin Hu

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Keito Hoshitsuki

University of Pittsburgh

UNITED STATES

View details

Omer Jamy

The University of Alabama

UNITED STATES

View details

Reuben M. Tooze

University of Leeds

UNITED KINGDOM

View details

Sarah E. Coupland

University of Liverpool

UNITED KINGDOM

View details

Lucy Cook

Honorary Senior Clinical Lecturer

Imperial College London

UNITED KINGDOM

View details

Vaskar Saha

The University of Manchester

UNITED KINGDOM

View details

Rishi Kotecha

Laboratory Head

Telethon Kids Institute

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Choi

Research Interests

Explore related searches

Contact this professor

Articles (15)

Prospective Evaluation of the Pathologic Diagnosis and Treatment Outcomes of Pediatric Burkitt Lymphoma in the Central American Pediatric Hematology-Oncology Association Consortium

Pediatric lymphomas: overview and diagnostic challenges

Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2/STAG2 rearrangements as extremely high-risk.

Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Acute Lymphoblastic Leukemias, Mixed-Phenotype Acute Leukemias, Myeloid/Lymphoid Neoplasms With Eosinophilia, Dendritic/Histiocytic Neoplasms, and Genetic Tumor Syndromes

Author Correction: Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia (Nature Communications, (2023), 14, 1, (809), 10.1038/s41467-023-36370-x)

Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia

Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia

Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group

Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia

Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimen

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031

Collaborators (16)

Kikkeri N Naresh

Javeed Iqbal

Pankit Vachhani

Brian Walker

Nicholas Cross

Karen M. Chisholm

Pedro Farinha

Catalina Amador

Shimin Hu

Keito Hoshitsuki

Omer Jamy

Reuben M. Tooze

Sarah E. Coupland

Lucy Cook

Vaskar Saha

Rishi Kotecha

Make your next move.